미래아이앤지

This profile gathers the share dealings of 미래아이앤지 in 케이바이오랩스. The record holds 31 filings, for trades running from 19 April 2021 to 4 September 2026.

The open-market side counts 7 purchases for €451k alongside 15 sales. The totals exclude 20 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 3 purchases and 1 sale.

Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 4 September 2026 came the latest disclosure, a transaction in 케이바이오랩스. The last purchase on record was published on 14 August 2026, which is 87 days ago. The median gap between a trade and its publication by DART (FSS) is 5 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.